A Case of Combined Infection with Tick-Borne Encephalitis and Lyme Borreliosis with Severe Meningoencephalitis and Complete Recovery : Journal of Global Infectious Diseases

Secondary Logo

Journal Logo

Case Report

A Case of Combined Infection with Tick-Borne Encephalitis and Lyme Borreliosis with Severe Meningoencephalitis and Complete Recovery

Ostapchuk, Yekaterina O.1,2; Dmitrovskiy, Andrey M.1,3,; Pak, Elena A.4; Perfilyeva, Yuliya V.1,2

Author Information
Journal of Global Infectious Diseases 15(2):p 81-83, Apr–Jun 2023. | DOI: 10.4103/jgid.jgid_76_22
  • Open


Here, we present a case of severe meningoencephalitis caused by combined infection with tick-borne encephalitis (TBE) and Lyme borreliosis (LB) in a 25-year-old woman in a rural area of Zhambyl region, Kazakhstan. She presented with fever, nausea, vomiting, weakness, sweating, severe headache, arthralgia, and malaise. The course of illness was further complicated by encephalitis with symmetric lesions of the midbrain cerebral peduncles and serous meningitis. TBE and LB co-infection were established by a two-fold increase in serum IgG titers between day 21 and day 25 of illness. Both infections responded well to combined therapy with human TBE immunoglobulins, antibiotics, antiviral drugs, glucocorticoids, and diuretics. The outcome of the disease was favorable and the patient recovered completely.


In Central Europe and many parts of Asia, tick-borne encephalitis virus (TBEV) and Borrelia burgdorferi sensu lato (s. l.), the causative agents of tick-borne encephalitis (TBE) and Lyme borreliosis (LB) are the two most important tick-borne pathogens that can lead to severe neurological complications.[1] Although several cases of co-infection with TBE and LB have been reported, there are limited data on the severe cases with prolonged meningoencephalitis followed by complete recovery of the patient.[1–3] Here, we describe a case of severe TBE and Lyme neuroborreliosis (LNB) co-infection in a woman from the Zhambyl region of Kazakhstan.


A 25-year-old woman presented with a fever lasting 9 days. She was inactive, had nausea, vomiting, weakness, sweating, severe headache, arthralgia, and malaise. Low titers of antibodies to Brucella bacteria were noted in the indicative Haddlson (+) and confirmatory Wright (1:50) agglutination reactions. Urinalysis showed elevated protein levels and the presence of leukocytes and erythrocytes [Table 1]. A presumptive diagnosis of brucellosis was made, and the patient started empiric treatment with nonsteroidal anti-inflammatory drugs, glucocorticoids, and kanamycin.

Table 1:
Laboratory findings

On day 13, the patient showed convulsions, unconsciousness, stupor, mild neck muscle stiffness, and clonic muscle spasms of the upper and lower limbs. Magnetic resonance imaging (MRI) examination revealed brainstem encephalitis with symmetric lesions in the midbrain cerebral peduncles, dyscirculatory encephalopathy, and signs of increased intracranial pressure. Analysis of the cerebrospinal fluid (CSF) showed mild pleocytosis with high lymphocyte counts and protein concentrations. Blood and CSF culture results were negative [Table 1]. On day 16, pupils were constricted and fixed to the center. Acute meningoencephalitis of unknown etiology was diagnosed and treatment was supplemented with intravenous medovir and ofloxacin.

On day 20, the patient was unable to fix her gaze, opened her mouth with difficulty, and the movement of the eyeballs was limited. Tongue tremors, hypomimia, and extrapyramidal muscle hypertonus were observed. The patient had no control over pelvic functions. On day 21, the serologic analysis revealed negative results for IgM and positive results for IgG antibodies against TBEV and B. burgdorferi s. l. On day 25, the serological analysis showed a two-fold increase in IgG titers against both TBEV and B. burgdorferi s. l. Human immunoglobulin against TBEV (international nonproprietary name – immunoglobulin encephalitis Ixodidae) and ceftriaxone (14.3 mg/kg × 2 doses for 13 days) intravenously were added to the treatment.

Over the next 12 days, the patient’s level of consciousness improved and facial and ocular palsies disappeared. The meningeal symptoms disappeared on day 34, and the patient was completely afebrile on day 38 after the onset of symptoms. She was discharged on day 39 with near complete improvement and underwent long-term rehabilitation. One year after discharge, she had fully recovered and showed no neurologic sequelae.


Clinical recognition of combined infections is always complex because of overlapping or distorted manifestations of one or both joint infections. This case illustrates the challenges in establishing a diagnosis in a patient with TBE and LNB co-infection that resulted in severe meningoencephalitis. Acute onset of symptoms, toxemia, meningoencephalitis syndrome, lymphocytic pleocytosis in the CSF, flaccid paralysis, cranial nerve involvement, and facial hypomimia are equally compatible with TBE or LNB.[2] The clinical diagnosis of double infection was supported by a two-fold increase in the titers of IgG antibodies against TBEV and B. burgdorferi s. l. in paired serum samples. TBE develops within a few weeks,[4] and the presence of TBE-specific IgM antibodies is usually recommended to confirm the diagnosis of TBE. Interestingly, in our case, IgM antibodies against TBEV were negative despite the acute illness. Several studies have described the same phenomenon.[5] Based on the clinical signs, MRI data, and laboratory findings, we consider the diagnosis of TBE in the patient to be well-established.

Laboratory diagnosis of LB is more difficult because infection with other tick-borne diseases or some viral and bacterial infections can lead to false-positive test results for LB.[6] Encephalitic symptoms caused by LNB occur in the late stage of the disease and may be observed months or even years after primary infection. In these cases, positive IgG and negative IgM results are considered reliable for establishing the diagnosis of LNB.[7] In our case, an increased titer of IgG antibodies to B. burgdorferi s. l. in paired sera collected at a short interval supported the diagnosis of LNB.

The establishment of the diagnosis in our case was also challenged by the fact that TBE and LB are not endemic in the Zhambyl region of Kazakhstan.[8] Examination of the patient revealed that she had recently traveled to the endemic areas for TBE and LB, Almaty Region of Kazakhstan.[8] The patient denied a tick bite and symptoms of LB in the past, which is not unusual. It was demonstrated that only 50%60% of patients with TBE and LB report tick bites.[4,7]

In Kazakhstan, TBE frequently causes meningoencephalitis leading to postencephalitic syndrome and long-term neurological morbidity.[4] Around 31.8% of TBE cases with meningoencephalitis results in upper limb paresis.[9] In the presented case, despite the severe form of meningoencephalitis, the outcome was favorable; the patient recovered completely and had no neurologic sequelae. After a diagnosis of co-infection with TBE and LNB was made, the patient was treated with human immunoglobulins against TBEV and ceftriaxone. Ceftriaxone is a preferred drug for LNB therapy.[1] Although there is no specific antiviral treatment for TBE,[4] intravenous human immunoglobulins against TBE have long been used for postexposure prophylaxis and TBE treatment. The efficacy of intravenous immunoglobulins against TBEV has not been demonstrated in clinical trials, several studies have reported their efficacy in the treatment of various clinical forms of TBE.[10] Therefore, we believe that co-infection with TBE and LNB can be successfully treated with a combination of human immunoglobulins against TBEV and antibiotics. Furthermore, this study demonstrates that patients with acute neurologic symptoms traveling to endemic areas should be evaluated for TBE and LB.

The study has several limitations. The TBEV RNA detection in the serum, CSF, or urine during the acute phase of infection was not performed due to the lack of diagnostic resources in the hospital. Furthermore, anti-TBEV antibodies were not tested in CSF, whereas it is recommended to perform for confirmation of the diagnosis.

Research quality and ethics statement

The authors followed applicable EQUATOR Network (http://www. equator-network. org/) guidelines, notably the CARE guideline, during the conduct of this report.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

This study was supported by the Science Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan under #AP14870683 “Distribution and genetic characterization of causative agents of tick-borne relapsing fevers (Relapsing Fever Borrelia) in the southern region of Kazakhstan”.

Conflicts of interest

There are no conflicts of interest.


1. Bröker M. Following a tick bite:Double infections by tick-borne encephalitis virus and the spirochete Borrelia and other potential multiple infections. Zoonoses Public Health 2012;59:176–80.
2. Amosov ML, Lesnyak OM, Obraztsova RG, Melnikov VG, Bardina TG, Andreeva YA. Clinical characteristics of tick-borne encephalitis in mixed infection with Lyme borrelliosis. Vopr Virusol 2000;45:25–8.
3. Etenko DA, Gromova OA, Subbotin AV, Semenov VA. Combination therapy for the focal form of mixed tick-borne encephalitis and borreliosis infection. Neurol Neuropsychiatr Psychosom 2016;8:26–30.
4. Kahl O, Vatslavovna Pogodina V, Poponnikova T, Süss J, Zlobin V. A short history of TBE Dobler G, Erber W, Bröker M, Schmitt HJ. The TBE Book. 2nd ed., Ch. 1. Singapore:Global Health Press;2019:11–8 Available from: https://doi.org/10.33442/978-981-14-0914-1_1. [Last accessed on 2021 Nov 10].
5. Vilibic-Cavlek T, Barbic L, Stevanovic V, Petrovic G, Mlinaric-Galinovic G. IgG avidity:An important serologic marker for the diagnosis of tick-borne encephalitis virus infection. Pol J Microbiol 2016;65:119–21.
6. Lyme Disease: Diagnosis and Testing. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/lyme/diagnosistesting/index.html. [Last accessed on 2021 May 21].
7. Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, et al. Guidelines for diagnosis and treatment in neurology –Lyme neuroborreliosis. Ger Med Sci 2020;18:Doc03.
8. Perfilyeva YV, Shapiyeva ZZ, Ostapchuk YO, Berdygulova ZA, Bissenbay AO, Kulemin MV, et al. Tick-borne pathogens and their vectors in Kazakhstan –A review. Ticks Tick Borne Dis 2020;11:101498.
9. Malov IV, Borisov VA, Tarbeev AK, Aitov KA. Ixodid Tick Infections in the Practice of a District Physician. Irkutsk: Ministry of Public Health and Social Development of Russian Federation Irkutsk Stat Medical Universiti Irkutsk; 2007.
10. Olefir UV, Merkulov VA, Vorobieva MS, Rukavishnikov AV, Shevtsov VA. Russian preparation of human immunoglobulin for urgent prophylaxis and treatment of tick-borne encephalitis. Immunologiya 2015;36:353–7.

Borrelia burgdorferi s. l; Kazakhstan; lyme neuroborreliosis; meningoencephalitis; tick-borne encephalitis; tick-borne encephalitis virus

Copyright: © 2023 Journal of Global Infectious Diseases